BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8677510)

  • 1. [A randomized comparison of adjuvant radiation therapy alone with sequential chemo-/radiotherapy in the treatment of resected non-small-cell bronchial carcinoma (NSCLC)].
    Rübe C
    Strahlenther Onkol; 1996 Jun; 172(6):345-6. PubMed ID: 8677510
    [No Abstract]   [Full Text] [Related]  

  • 2. [With reference to later intra-/extrathoracic recurrence manifestations also after so-called radical operation: when are (neo-)adjuvant measures indicated?].
    Drings P
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():805-9. PubMed ID: 9101994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer adjuvant therapy.
    Horn L; Sandler A
    Cancer J; 2007; 13(3):210-6. PubMed ID: 17620772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
    Papadakis E
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S25-8. PubMed ID: 11924238
    [No Abstract]   [Full Text] [Related]  

  • 5. [Curative radiotherapy in locally advanced non-small-cell bronchial carcinoma (NSCLC)].
    von Briel C; Betticher DC; Ris HB
    Ther Umsch; 1998 Jul; 55(7):402-4. PubMed ID: 9702103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
    Moro D
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S22-4. PubMed ID: 11924237
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined modality therapy for non-small cell lung carcinoma.
    Machtay M; Glatstein E
    Cancer J; 2002; 8 Suppl 1():S55-67. PubMed ID: 12075703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
    Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ;
    J Clin Oncol; 2005 May; 23(15):3480-7. PubMed ID: 15908657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommendations on the therapy of bronchial carcinoma].
    Thomas M; Baumann M; Deppermann M; Freitag L; Gatzemeier U; Huber R; Passlick B; Serke M; Ukena D
    Pneumologie; 2002 Feb; 56(2):113-31. PubMed ID: 11842350
    [No Abstract]   [Full Text] [Related]  

  • 10. Resected non-small-cell lung cancer stage I/II: indication for adjuvant/neoadjuvant therapy?
    Hoffmann H
    Lung Cancer; 2004 Aug; 45 Suppl 2():S91-7. PubMed ID: 15552788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status of interdisciplinary therapy of stage III non-small-cell bronchial carcinoma].
    Manegold C; Schirren J; Schneider P; Drings P; Vogt-Moykopf I; Schraube P; Wannenmacher M
    Pneumologie; 1996 Oct; 50(10):735-41. PubMed ID: 9019754
    [No Abstract]   [Full Text] [Related]  

  • 12. [Postoperative adjuvant therapy for 189 patients with completely resected non-small cell lung cancer of stage III(A)].
    Li Q; Gao JM; Liang PY; Xie FY; Liu GZ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1463-6. PubMed ID: 15566658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials.
    Hotta K; Matsuo K; Ueoka H; Kiura K; Tabata M; Tanimoto M
    J Clin Oncol; 2004 Oct; 22(19):3860-7. PubMed ID: 15326194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New therapeutic strategies and current research in inoperable locally advanced non small-cell lung cancers (stage IIIB)].
    Le Cesne A; Arriagada R; Grunenwald D; Baldeyrou P; Girard P; Bretel JJ; Le Chevalier T
    Bull Cancer; 1997 Apr; 84(4):413-9. PubMed ID: 9238166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On ''Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma: what is the answer?''].
    González Aragoneses F
    Arch Bronconeumol; 2007 Mar; 43(3):183-4; author reply 184. PubMed ID: 17386198
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer.
    Hotta K; Matsuo K; Kiura K; Ueoka H; Tanimoto M
    Curr Opin Oncol; 2006 Mar; 18(2):144-50. PubMed ID: 16462183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Response to an alternated chemo-radiotherapeutic treatment as neoadjuvant therapy of non-small-cell lung carcinoma (NSCLC). Report of a clinical case].
    Della Vittoria Scarpati M; De Vita F; Rippa A; Gattoni A; Pilerci N; Catalano G
    G Ital Chemioter; 1991; 38(1-3):209-10. PubMed ID: 1365597
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent issues in the treatment of advanced non-small-cell lung cancer].
    Negoro S
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1671-9. PubMed ID: 9757191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
    Tanaka F; Wada H
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):300-6. PubMed ID: 16531708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancer.
    Belani CP
    Clin Lung Cancer; 2005 May; 6(6):331-2. PubMed ID: 15943890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.